134
Participants
Start Date
April 7, 2025
Primary Completion Date
October 31, 2026
Study Completion Date
April 30, 2027
Carboplatin for injection/cisplatin for injection + etoposide injection + benmelstobart injection + Anlotinib hydrochloride capsule
Carboplatin for injection inhibits DNA synthesis, thereby preventing cancer cell division and reproduction/Cisplatin for injection binds to DNA, interfering with DNA replication and transcription processes, Thus inhibiting tumor cell proliferation/etoposide injection interferes with the division process of cancer cells to inhibit their growth and spread/Bemosubebezumab injection is a humanized recombinant anti-Programmed cell death ligand 1 (PD-L1) monoclonal antibody/Anlotinib hydrochloride capsule is a tyrosine kinase inhibitor.
Carboplatin for injection/Cisplatin for injection + etoposide injection + Tislelizumab injection
Carboplatin for injection inhibits DNA synthesis and thus prevents the division and reproduction of cancer cells/Cisplatin for injection binds to DNA and interferes with the DNA replication and transcription process, thereby inhibiting the proliferation of tumor cells/etoposide injection interferes with the division process of cancer cells to inhibit their growth and spread/Tislelizumab injection is a humanized recombinant anti-PD-1 monoclonal antibody.
NOT_YET_RECRUITING
Shanxi Cancer hospital, Taiyuan
RECRUITING
Cancer Hospital Chinese Academy of Medical Sciences, Beijing
NOT_YET_RECRUITING
Peking University People´s Hospital, Beijing
NOT_YET_RECRUITING
Beijing Cancer Hospital, Beijing
NOT_YET_RECRUITING
Liaoning Cancer Hospital & Institute, Shenyang
NOT_YET_RECRUITING
The First Affiliated Hospital of China Medical University, Shenyang
NOT_YET_RECRUITING
The First Affiliated Hospital of Harbin Medical University, Harbin
NOT_YET_RECRUITING
Jiangsu Cancer Hospital, Nanjing
NOT_YET_RECRUITING
Maanshan People's Hospital, Maanshan
RECRUITING
The First Affiliated Hospital of Shandong First Medical University, Jinnan
NOT_YET_RECRUITING
Linyi City People's Hospital, Linyi
NOT_YET_RECRUITING
Ningbo Medical Center Lihuili Hospital, Ningbo
NOT_YET_RECRUITING
Ningbo No.2 Hospital, Ningbo
NOT_YET_RECRUITING
Taizhou Hospital of Zhejiang Province, Taizhou
NOT_YET_RECRUITING
Fujian Medical University 2nd Affiliated Hospital, Quanzhou
NOT_YET_RECRUITING
The Second Xiangya Hospital of Central South University, Changsha
NOT_YET_RECRUITING
Huazhong University of Science and Technology Tongji Medical College of Huazhong University of Science and Technology, Wuhan
NOT_YET_RECRUITING
Henan Provincial People'S Hospital, Zhengzhou
NOT_YET_RECRUITING
Henan Cancer Hospital Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou
NOT_YET_RECRUITING
Cancer Hospital of Shantou University Medical College, Shantou
NOT_YET_RECRUITING
Nanfang Hospital, Guangzhou
NOT_YET_RECRUITING
Dongyang Municipal People's Hospital, Dongyang
NOT_YET_RECRUITING
Sichuan cancer hospital, Chengdu
NOT_YET_RECRUITING
The Second Affiliated Hospital Of Xi'an Jiaotong University, Xi'an
NOT_YET_RECRUITING
The Second Hospitai. & Clinicae Medical School . Lanzhou University, Lanzhou
NOT_YET_RECRUITING
The fourth hospital of hebei medical university, Shijiazhuang
NOT_YET_RECRUITING
Tangshan People's Hospital, Tangshan
NOT_YET_RECRUITING
Baotou Cancer Hospital, Baotou
Lead Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
INDUSTRY